Ligand Pharmaceuticals Incorporated Uncategorized Contracts & Agreements

26 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Tax Matters Agreement among OmniAb, Inc., Ligand Pharmaceuticals Incorporated, and OmniAb Operations, Inc. dated November 1, 2022
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2022
Contingent Value Rights Agreement between Ligand Pharmaceuticals Incorporated and Vaughn Smider as Members’ Representative (September 9, 2020)
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2020
Break Fee Letter Agreement between Ligand Holdings UK Ltd. and Vernalis plc (August 9, 2018)
Ligand Pharmaceuticals Incorporated
Biotechnology
2018
Confirmation of Additional Convertible Bond Hedge Transaction between Goldman Sachs & Co. LLC and Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Consent of Independent Registered Public Accounting Firm by Frank, Rimerman + Co. LLP for Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
Biotechnology
2016
Contingent Value Rights Agreement among Ligand Pharmaceuticals, CyDex Pharmaceuticals, and Shareholders’ Representatives (2011)
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2011
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services (2010)
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2010
Glucagon Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2010
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services (2010)
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2010
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2010
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Registrar and Transfer Company (Real Estate CVRs)
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Registrar and Transfer Company
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Registrar and Transfer Company
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Aplindore Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Registrar and Transfer Company (2009)
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Glucagon Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Metabasis Therapeutics, Stockholders’ Representative, and Mellon Investor Services
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Contingent Value Rights Agreement Relating to Real Estate—Ligand Pharmaceuticals, Neurogen Corporation, and Rights Agent
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Rights Agent (Merck CVR)
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Rights Agent
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Aplindore Contingent Value Rights Agreement among Ligand Pharmaceuticals, Neurogen Corporation, and Rights Agent
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Pharmacopeia, and Mellon Investor Services (2008)
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2008
Contingent Value Rights Agreement among Ligand Pharmaceuticals, Pharmacopeia, and Rights Agent
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2008
First Amendment to Manufacturing and Packaging Agreement between Ligand Pharmaceuticals Incorporated and Cardinal Health PTS, LLC
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2006
Lock-Up Agreement between Ligand Pharmaceuticals Incorporated and Option Holders
Ligand Pharmaceuticals Incorporated
Biotechnology
2005